Dedicated 3D-T2-STIR-ZOOMit Imaging Improves Demyelinating Lesion Detection in the Anterior Visual Pathways of Patients with Multiple Sclerosis

References

1. 1.↵
   2. Reich DS,
   3. Lucchinetti CF,
   4. Calabresi PA

   . Multiple sclerosis. N Engl J Med 2018;378:169–80 doi:10.1056/NEJMra1401483 pmid:29320652

   CrossRefPubMed
2. 2.↵
   2. Dutra BG,
   3. Da Rocha AJ,
   4. Nunes RH, et al

   . Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis. Radiographics 2018;38:169–93 doi:10.1148/rg.2018170141 pmid:29320331

   CrossRefPubMed
3. 3.↵
   2. Ulrich J,
   3. Groebke-Lorenz W

   . The optic nerve in multiple sclerosis: a morphological study with retrospective clinico-pathological correlations. Neuro-Ophthalmology 1983;3:149–59 doi:10.3109/01658108309009732

   CrossRef
4. 4.↵
   2. Balcer LJ,
   3. Frohman EM

   . Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Neurology 2010;74:S16–23 doi:10.1212/WNL.0b013e3181dbb664 pmid:20421569

   Abstract/FREE Full Text
5. 5.↵
   2. Filippi M,
   3. Rocca MA,
   4. Ciccarelli O, et al

   . MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292–303 doi:10.1016/S1474-4422(15)00393-2 pmid:26822746

   CrossRefPubMed
6. 6.↵
   2. Thompson AJ,
   3. Banwell BL,
   4. Barkhof F, et al

   . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162–73 doi:10.1016/S1474-4422(17)30470-2 pmid:29275977

   CrossRefPubMed
7. 7.↵
   2. Sormani MP,
   3. De Stefano N

   . Defining and scoring response to IFN-β in multiple sclerosis. Nat Rev Neurol 2013;9:504–12 doi:10.1038/nrneurol.2013.146 pmid:23897407

   CrossRefPubMed
8. 8.↵
   2. Petzold A,
   3. Wattjes MP,
   4. Costello F, et al

   . The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 2014;10:447–58 doi:10.1038/nrneurol.2014.108 pmid:25002105

   CrossRefPubMed
9. 9.↵
   2. Polman CH,
   3. Reingold SC,
   4. Banwell B, et al

   . Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald Criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Blasche M,
    3. Riffel P,
    4. Lichy M

    . TimTX TrueShape and syngo ZOOMit: technical and practical aspects. MAGNETOM Flash 2012 https://cdn0.scrvt.com/39b415fb07de4d9656c7b516d8e2d907/1800000000118051/a06d5db36c83/TimTX_TrueShape_and_syngo_Zoomit_Aspects_1800000000118051.pdf. Accessed January 01, 2020
11. 11.↵
    2. Fang S,
    3. Bai HX,
    4. Fan X, et al

    . A novel sequence: ZOOMit-blood oxygen level-dependent for motor-cortex localization. Clin Neurosurg 2020;86:E124–32 doi:10.1093/neuros/nyz441 pmid:31642505

    CrossRefPubMed
12. 12.↵
    2. Bot JC,
    3. Barkhof F,
    4. Lycklama À, et al

    . Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesion in multiples sclerosis. Eur Radiol 2000;10:753–58 doi:10.1007/s003300050998 pmid:10823627

    CrossRefPubMed
13. 13.↵
    2. Thorpe JW,
    3. MacManus DG,
    4. Kendall BE, et al

    . Short tau inversion recovery fast spin-echo (fast STIR) imaging of the spinal cord in multiple sclerosis. Magn Reson Imaging 1994;12:983–89 doi:10.1016/0730-725X(94)91228-O pmid:7997103

    CrossRefPubMed
14. 14.↵
    2. Hodel J,
    3. Outteryck O,
    4. Bocher AL, et al

    . Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study. Eur Radiol 2014;24:3069–75 doi:10.1007/s00330-014-3342-3

    CrossRefPubMed
15. 15.↵
    2. Kurtzke JF

    . Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444–52 doi:10.1212/wnl.33.11.1444 pmid:6685237

    Abstract/FREE Full Text
16. 16.↵
    2. Geraldes R,
    3. Ciccarelli O,
    4. Barkhof F, et al

    . MAGNIMS study group. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol 2018;14:199–213 doi:10.1038/nrneurol.2018.14 pmid:29582852

    CrossRefPubMed
17. 17.↵
    2. Bink A,
    3. Schmitt M,
    4. Gaa J, et al

    . Detection of lesions in multiple sclerosis by 2D FLAIR and single-slab 3D FLAIR sequences at 3.0 T: initial results. Eur Radiol 2006;16:1104–10 doi:10.1007/s00330-005-0107-z pmid:16425026

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Molyneux PD,
    3. Tubridy N,
    4. Parker GJ, et al

    . The effect of section thickness on MR lesion detection and quantification in multiple sclerosis. AJNR Am J Neuroradiol 1998;19:1715–20 pmid:30446963

    Abstract
19. 19.↵
    2. Moraal B,
    3. Roosendaal SD,
    4. Pouwels PJ, et al

    . Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis. Eur Radiol 2008;18:2311–20 doi:10.1007/s00330-008-1009-7 pmid:18509658

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Kallmes DF,
    3. Hui FK,
    4. Mugler JP

    . Suppression of cerebrospinal fluid and blood flow artifacts in FLAIR MR imaging with a single-slab three-dimensional pulse sequence: Initial experience. Radiology 2001;221:251–55 doi:10.1148/radiol.2211001712 pmid:11568348

    CrossRefPubMed
21. 21.↵
    2. Kneeland JB,
    3. Shimakawa A,
    4. Wehrli FW

    . Effect of intersection spacing on MR image contrast and study time. Radiology 1986;158:819–22 doi:10.1148/radiology.158.3.3945757 pmid:3945757

    CrossRefPubMed
22. 22.↵
    2. Sartoretti T,
    3. Sartoretti E,
    4. Rauch S, et al

    . How common is signal-intensity increase in optic nerve segments on 3D double inversion recovery sequences in visually asymptomatic patients with multiple sclerosis? AJNR Am J Neuroradiol 2017;38:1748–53 doi:10.3174/ajnr.A5262 pmid:28663263

    Abstract/FREE Full Text
23. 23.↵
    2. Hadhoum N,
    3. Hodel J,
    4. Defoort-Dhellemmes S, et al

    . Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss. Mult Scler 2016;22:649–58 doi:10.1177/1352458515598021 pmid:26227005

    CrossRefPubMed
24. 24.↵
    2. Riederer I,
    3. Mühlau M,
    4. Hoshi MM, et al

    . Detecting optic nerve lesions in clinically isolated syndrome and multiple sclerosis: double-inversion recovery magnetic resonance imaging in comparison with visually evoked potentials. J Neurol 2019;266:148–56 doi:10.1007/s00415-018-9114-2 pmid:30446963

    CrossRefPubMed
25. 25.↵
    2. Traboulsee A,
    3. Simon JH,
    4. Stone L, et al

    . Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol 2016;37:394–401 doi:10.3174/ajnr.A4539 pmid:26564433

    Abstract/FREE Full Text
26. 26.↵
    2. Yuhasz M,
    3. Hoch MJ,
    4. Hagiwara M, et al

    . Accelerated internal auditory canal screening magnetic resonance imaging protocol with compressed sensing 3-dimensional T2-weighted sequence. Invest Radiol 2018;53:742–47 doi:10.1097/RLI.0000000000000499 pmid:30020139

    CrossRefPubMed
27. 27.↵
    2. Fritz J,
    3. Fritz B,
    4. Thawait GG, et al

    . Three-dimensional CAIPIRINHA SPACE TSE for 5-minute high-resolution MRI of the knee. Invest Radiol 2016;51:609–17 doi:10.1097/RLI.0000000000000287 pmid:27187045

    CrossRefPubMed
28. 28.↵
    2. White N,
    3. Roddey C,
    4. Shankaranarayanan A, et al

    . PROMO: real-time prospective motion correction in MRI using image-based tracking. Magn Reson Med 2010;63:91–105 doi:10.1002/mrm.22176 pmid:20027635

    CrossRefPubMed